Cell Isolation Market is Expecting Major Revenue Surge by 2025


Posted June 21, 2022 by vmack2187

This study involved four major activities in estimating the current size of the cell isolation market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
 
Overview:

This study involved four major activities in estimating the current size of the cell isolation market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the cell isolation market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry have been identified through extensive secondary research
# The revenues generated by leading players operating in the cell isolation market have been determined through primary and secondary research
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Expected Revenue Gains:

The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9 billion in 2020, at a CAGR of 16.8%.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

COVID-19 Impact on Cell Isolation Market:

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020.

Currently, various organizations are supporting the use of stem cells or regenerative medicine for vaccine development.

The governing board of the California Institute for Regenerative Medicine (CIRM) approved USD 5 million in funding for peer-reviewed regenerative medicine and stem cell research that could quickly advance treatments for COVID-19.

Stem Cell Network (SCN) is providing up to USD 500,000 in funding to support rapid response research that uses a stem cell or regenerative medicine approach for addressing COVID-19.

Opportunity: Emerging Markets

Emerging countries, especially in the Asia Pacific region, are expected to become a focal point for growth in the cell isolation market. The increasing investments in cell biology research and the growing presence of market players in emerging regions are the major factors responsible for the high growth of the cell isolation market in these countries. For instance, pharmaceutical companies based in India are making significant investments in R&D in order to introduce new drugs in the market. Dr. Reddy’s Laboratories, one of the major players in the Indian pharmaceutical market, spent USD 297 million on R&D in 2017. Such investments are expected to increase the demand for cell isolation products in the country in the coming years.

Recent Developments:

# In May 2019, Thermo Fisher Scientific acquired Brammer Bio with the aim to expand capabilities to support the high growth gene and cell therapy market.
# In October 2018, Merck opened its M Lab Collaboration Center in São Paulo
# In May 2019, Beckman Coulter launched ClearLLab 10C System

North America is the largest regional market for cell isolation market

The cell isolation market is segmented into four regions, namely, North America, Europe, Asia Pacific and Rest of the world. In 2019, North America accounted for the largest share of the cell isolation market. The large share of North America can be attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Biotech , Industry , Research
Tags cell isolation , cell isolation market
Last Updated June 21, 2022